Inês P Marques1,2, Sophie Kubach3, Torcato Santos1, Luís Mendes1, Maria H Madeira1,2, Luis de Sisternes3, Diana Tavares1, Ana Rita Santos1,4, Warren Lewis3, Conceição Lobo1,2,5, Mary K Durbin3, José Cunha-Vaz1,2. 1. AIBILI-Association for Innovation and Biomedical Research on Light and Image, 3000-548 Coimbra, Portugal. 2. Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal. 3. Research and Development, Carl Zeiss Meditec, Dublin, CA 94568, USA. 4. Department of Orthoptics, School of Health, Polytechnic of Porto, 4200-072 Porto, Portugal. 5. Department of Ophthalmology, Centro Hospitalar e Universitário de Coimbra (CHUC), 3000-075 Coimbra, Portugal.
Abstract
To examine retinal vessel closure metrics and neurodegenerative changes occurring in the initial stages of nonproliferative diabetic retinopathy (NPDR) and severity progression in a three-year period. Methods: Three-year prospective longitudinal observational cohort of individuals with type 2 diabetes (T2D), one eye per person, using spectral domain-optical coherence tomography (SD-OCT) and OCT-Angiography (OCTA). Eyes were examined four times with one-year intervals. OCTA vessel density maps of the retina were used to quantify vessel closure. Thickness of the ganglion cell + inner plexiform layer (GCL + IPL) was examined to identify retinal neurodegenerative changes. Diabetic retinopathy ETDRS classification was performed using the seven-field ETDRS protocol. Results: A total of 78 eyes/patients, aged 52 to 80 years, with T2D and ETDRS grades from 10 to 47 were followed for 3 years with annual examinations. A progressive increase in retinal vessel closure was observed. Vessel density (VD) showed higher decreases with retinopathy worsening demonstrated by step-changes in ETDRS severity scale (p < 0.001). No clear correlation was observed between neurodegenerative changes and retinopathy progression. Conclusions: Retinal vessel closure in NPDR correlates with DR severity progression. Our findings provide supporting evidence that OCTA metrics of vessel closure may be used as a surrogate for DR severity progression.
To examine retinal vessel closure metrics and neurodegenerative changes occurring in the initial stages of nonproliferative diabetic retinopathy (NPDR) and severity progression in a three-year period. Methods: Three-year prospective longitudinal observational cohort of individuals with type 2 diabetes (T2D), one eye per person, using spectral domain-optical coherence tomography (SD-OCT) and OCT-Angiography (OCTA). Eyes were examined four times with one-year intervals. OCTA vessel density maps of the retina were used to quantify vessel closure. Thickness of the ganglion cell + inner plexiform layer (GCL + IPL) was examined to identify retinal neurodegenerative changes. Diabetic retinopathyETDRS classification was performed using the seven-field ETDRS protocol. Results: A total of 78 eyes/patients, aged 52 to 80 years, with T2D and ETDRS grades from 10 to 47 were followed for 3 years with annual examinations. A progressive increase in retinal vessel closure was observed. Vessel density (VD) showed higher decreases with retinopathy worsening demonstrated by step-changes in ETDRS severity scale (p < 0.001). No clear correlation was observed between neurodegenerative changes and retinopathy progression. Conclusions: Retinal vessel closure in NPDR correlates with DR severity progression. Our findings provide supporting evidence that OCTA metrics of vessel closure may be used as a surrogate for DR severity progression.
Authors: Qi Sheng You; Jie Wang; Yukun Guo; Shaohua Pi; Christina J Flaxel; Steven T Bailey; David Huang; Yali Jia; Thomas S Hwang Journal: Am J Ophthalmol Date: 2020-04-29 Impact factor: 5.258
Authors: Eugenia Custo Greig; Mitchell Brigell; Frank Cao; Emily S Levine; Kevin Peters; Eric M Moult; James G Fujimoto; Nadia K Waheed Journal: Am J Ophthalmol Date: 2020-06-20 Impact factor: 5.258
Authors: WooJhon Choi; Nadia K Waheed; Eric M Moult; Mehreen Adhi; ByungKun Lee; Talisa De Carlo; Vijaysekhar Jayaraman; Caroline R Baumal; Jay S Duker; James G Fujimoto Journal: Retina Date: 2017-01 Impact factor: 4.256
Authors: Rupert R A Bourne; Gretchen A Stevens; Richard A White; Jennifer L Smith; Seth R Flaxman; Holly Price; Jost B Jonas; Jill Keeffe; Janet Leasher; Kovin Naidoo; Konrad Pesudovs; Serge Resnikoff; Hugh R Taylor Journal: Lancet Glob Health Date: 2013-11-11 Impact factor: 26.763
Authors: Maria H Madeira; Inês P Marques; Sónia Ferreira; Diana Tavares; Torcato Santos; Ana Rita Santos; João Figueira; Conceição Lobo; José Cunha-Vaz Journal: Front Neurosci Date: 2021-12-21 Impact factor: 5.152